Context Therapeutics Inc.
CNTX
$2.36
-$0.12-4.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.00M | 76.94M | 83.52M | 89.35M | 94.43M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.16M | 1.92M | 3.23M | 3.18M | 3.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| Total Current Assets | 68.35M | 79.06M | 86.95M | 92.73M | 97.90M |
|
|
|||||
| Total Current Assets | 68.35M | 79.06M | 86.95M | 92.73M | 97.90M |
| Net Property, Plant & Equipment | 140.10K | 172.30K | 203.90K | 234.70K | 230.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 68.49M | 79.23M | 87.15M | 92.97M | 98.13M |
|
|
|||||
| Total Accounts Payable | 2.53M | 2.72M | 2.40M | 1.00M | 1.45M |
| Total Accrued Expenses | 5.34M | 3.16M | 2.01M | 710.40K | 1.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 112.10K | 119.00K | 115.00K | 111.10K | 107.30K |
| Total Finance Division Other Current Liabilities | 39.00K | 34.60K | 37.70K | 77.30K | 49.80K |
| Total Other Current Liabilities | 39.00K | 34.60K | 37.70K | 77.30K | 49.80K |
| Total Current Liabilities | 8.02M | 6.04M | 4.56M | 1.90M | 2.75M |
|
|
|||||
| Total Current Liabilities | 8.02M | 6.04M | 4.56M | 1.90M | 2.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 21.20K | 52.30K | 82.60K | 112.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.02M | 6.06M | 4.61M | 1.98M | 2.86M |
|
|
|||||
| Common Stock & APIC | 191.38M | 191.05M | 190.73M | 190.34M | 190.05M |
| Retained Earnings | -130.90M | -117.88M | -108.18M | -99.36M | -94.78M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 60.47M | 73.17M | 82.54M | 90.98M | 95.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.47M | 73.17M | 82.54M | 90.98M | 95.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 60.47M | 73.17M | 82.54M | 90.98M | 95.27M |
|
|
|||||